Preferences help
enabled [disable] Abstract
Number of results
2009 | 56 | 1 | 183-187
Article title

Selenium supplementation to chronic kidney disease patients on hemodialysis does not induce the synthesis of plasma glutathione peroxidase

Title variants
Languages of publication
Background: Numerous authors have shown that selenium (Se) concentration and glutathione peroxidase (GSH-Px) activity in plasma of chronic kidney disease (CKD) patients are lower than in healthy subjects, but there are only few publications on the level of GSH-Px protein in those patients and no reports on the effect of Se supplementation to HD patients on the level of this enzyme. Subjects and Methods: Se concentration and GSH-Px protein level in plasma were measured in a group of 30 CKD patients on hemodialysis (HD) supplemented with 200 µg Se/day for 3 months, and 28 patients on HD administered with placebo. Se concentration was measured by graphite furnace atomic absorption spectrometry and plasma GSH-Px protein level by the sandwich ELISA method using polyclonal antibody specific for human plasma GSH-Px. Results: Se concentration in patients on placebo did not change throughout the 3-month study period, but increased significantly in Se supplemented group. Se supplementation to CKD patients on HD had no effect on the level of GSH-Px protein. Conclusions: The lack of GSH-Px protein in CKD patients on HD is not linked to Se deficiency since the level of this element increased after Se supplementation while enzyme protein level did not change. The damaged kidney of HD patients is unable to synthesize GSH-Px, even after induction with selenium.
Physical description
  • Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Łódź, Poland
  • Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Łódź, Poland
  • B. Braun Avitum Dialysis Center, Łódź, Poland
  • B. Braun Avitum Dialysis Center, Łódź, Poland
  • Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Łódź, Poland
  • Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Łódź, Poland
  • Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Łódź, Poland
  • Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Łódź, Poland
  • Avissar N, Ornt DB, Yagil Y, Horovitz S, Watkins RH, Kerl EA, Takahashi K, Palmer IS, Cohen HJ (1994) Human kidney proximal tubules are the main source of plasma glutathione peroxidase. Am J Physiol 266: C367-C375.
  • Brigelius-Flohe R (2006) Glutathione peroxidases and redox-regulated transcription factors. Biol Chem 387: 1329-1335.
  • Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, Nguyen AT, Thevenin M, Jaudon MC, Zingraff J, Jungers P, Descamps-Latscha B (1996) Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Rad Biol Med 21: 845-853.
  • Chu FF, Esworthy S, Doroshow JH, Doan K, Liu XF (1992) Expression of plasma glutathione peroxidase in human liver in addition to kidney, heart, lung, and breast in humans and rodents. Blood 79: 3233-3238.
  • Donica H (2001) Evaluation of lipid peroxidation products vs. proinflammatory cytokines in hemodialyzed patients. Renal Failure 23: 231-238.
  • Jacobson GA, Narkowicz C, Tong YC, Peterson GM (2006) Plasma glutathione peroxidase by ELISA and relationship to selenium level. Clin Chim Acta 369: 100-103.
  • Kyriakopoulos A, Behne D (2002) Selenium-containing proteins in mammalian and other forms of life. Rev Physiol Biochem Pharmacol 145: 1-46.
  • McGill CR, Green NR, Meadows MC, Gropper SS (2003) Beta-caroten supplementation decreases leukocyte superoxide dismutase activity and serum glutathione peroxidase concentration in humans. J Nutr Biochem 14: 656-662.
  • Morrison DF (1990) Multivariate Statistical Methods (Polish edn). PWN, Warsaw.
  • Neve J, Chamart S, Molle L (1987) Optimization of direct procedure for the determination of selenium in plasma and erythrocytes using Zeeman effect atomic absorption spectroscopy. In Trace Elements Analytical Chemistry in Medicine and Biology, Bratter P, Schramel P, eds, 4: pp 349-358. Walter de Gruyter, Berlin.
  • Nishioka H, Kanauchi M, Dohi K (2001) The role of extracellular glutathione peroxidase in diabetic nephropathy. Nephron 87: 196-197.
  • Papp LV, Lu J, Holmgren A, Khanna KK (2007) From selenium to selenoproteins: Synthesis, identity, and their role in human health. Antioxid Redox Signal 9: 775-806.
  • Richard MJ, Duclos V, Foret M, Arnaud J, Coudray C, Fusselier M, Favier A (1993) Reversal of selenium and zinc deficiencies in chronic hemodialysis patients by intravenous sodium selenate and zinc gluconate supplementation. Time-course of glutathione peroxidase repletion and lipid peroxidation decrease. Biol Trace Elem Res 39: 149-159.
  • Rico MG, Puchades MJ, Ramon RG, Saez G, Tormos MC, Miguel A (2006) Effect of hemodialysis on oxidative stress in patients with chronic renal failure. Nefrologia 26: 218-225.
  • Roxborough HE, Mercer C, McMaster D, Young IS (1999) Plasma glutathione peroxidase activity is reduced in haemodialysis patients. Nephron 81: 278-283.
  • Saint-Georges MD, Bonnefont DJ, Bourely BA, Jaudon MC, Cereze P, Chaumeil P, Gard C, D'Auzac CL (1989) Correction of selenium deficiency in hemodialyzed patients. Kidney Int (Suppl) 27: S274-S277.
  • Xia Y, Hill KE, Byrne DW, Xu J, Burk RF (2005) Effectiveness of selenium supplementation in a low-selenium area of China. Am J Clin Nutr 81: 829-834.
  • Xia Y, Zhao X, Zhu L, Whanger PD (1992) Metabolism of selenate and selenomethionine by a selenium-deficient population of men in China. J Nutr Biochem 3: 202-210.
  • Yamamoto Y, Takekoshi Y, Itami N (1995) Enzyme-linked immunosorbent assay for extracellular glutathione peroxidase in serum of normal individuals and in patients with renal failure on hemodialysis. Clin Chim Acta 236: 93-99.
  • Yoshimura S, Suemizu H, Nomoto Y, Sakai H, Katsuoka Y, Kawamura N, Moriuchi T (1996) Plasma glutathione peroxidase deficiency caused by renal dysfunction. Nephron 73: 207-211.
  • Zachara BA, Adamowicz A, Trafikowska U, Pilecki A, Manitius J (2000) Decreased plasma glutathione peroxidase activity in uremic patients. Nephron 84: 278-279.
  • Zachara BA, Gromadzińska J, Wąsowicz W, Zbróg Z (2006) Red blood cell and plasma glutathione peroxidase activities and selenium concentration in patients with chronic kidney disease: A review. Acta Biochim Polon 53: 663-677.
  • Zachara BA, Koterska D, Manitius J, Sadowski L, Dziedziczko A, Salak A, Wasowicz W (2004a) Selenium supplementation on plasma glutathione peroxidase activity in patients with end-stage chronic renal failure. Biol Trace Elem Res 97: 15-30.
  • Zachara BA, Salak A, Koterska D, Manitius J, Wasowicz W (2004b) Selenium and glutathione peroxidases in blood of patients with different stages of chronic renal failure. J Trace Elem Med Biol 17: 291-299.
  • Zima T, Mestek O, Nemecek K, Bartova V, Fialova J, Tesar V, Suchanek M (1998) Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients. Blood Purif 16: 253-260.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.